The Defund Heroin Injection Centers Act of 2025 prohibits the use of any Federal funds for any State, local, Tribal, or private entity that "operates or controls an injection center" in violation of 21 U.S.C. 856 (the so‑called 'Crack House Statute'). The bill is short: a short title and a single operative section that conditions federal funding on compliance with that criminal statute.
This matters because the bill uses federal spending power to pressure jurisdictions, health providers, and nonprofits considering supervised or safe consumption sites. Its sparse text leaves key terms and enforcement details unspecified, creating immediate questions about which programs and which funds are at stake and how agencies would apply the prohibition in practice.
At a Glance
What It Does
The bill forbids Federal funds from being made available to any State, local, Tribal, or private entity that operates or controls an injection center in violation of 21 U.S.C. 856. It does not define "injection center," nor does it identify particular grant programs or funding mechanisms.
Who It Affects
Cities, counties, Tribal governments, public health departments, nonprofit harm‑reduction organizations, health systems, and private operators that run or plan supervised consumption facilities are directly affected. Federal grant programs that fund these entities are implicated even though the bill does not name specific funding streams.
Why It Matters
By conditioning funding on compliance with a federal criminal statute, the bill leverages federal dollars to influence state and local public‑health policy choices on overdose response and harm reduction. The lack of definitions and exceptions raises legal and operational uncertainty for agencies that administer federal grants and for entities planning services.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill contains two short parts: a short title and an operative prohibition. The operative text states that no Federal funds may be made available to any State, local, Tribal, or private entity that operates or controls an injection center in violation of 21 U.S.C. 856, the statute that criminalizes maintaining a place for the purpose of using controlled substances.
The language is categorical: if an entity ‘‘operates or controls’’ an injection center in violation of that federal statute, it cannot receive Federal funds.
Importantly, the bill does not attempt to amend 21 U.S.C. 856 itself or to define what constitutes an "injection center." It also does not identify which federal funds are covered, whether the prohibition is program‑specific or universal across all federal assistance, or whether agencies should implement prospective certification, retroactive clawbacks, or debarment. Those implementation details would fall to grantmaking agencies, the executive branch, or to subsequent litigation testing the scope of the funding restriction.Because the bill ties funding eligibility to compliance with a criminal statute, it creates a legal overlap between criminal law enforcement and federal spending rules.
Entities contemplating supervised consumption sites will need to consider both criminal liability under existing law and the risk that continuing to operate — or even planning to operate — a site could jeopardize unrelated federal grants. The bill also reaches private entities as well as governments, broadening its potential effect beyond publicly operated facilities.The text leaves several practical questions open: does the prohibition apply only after a criminal conviction under 21 U.S.C. 856, or can agencies treat an ongoing operation as a violation?
Does ‘‘operate or control’’ include landlords, vendors, or hosting organizations? And how should agencies reconcile statutory grant terms that require services (for example, certain public‑health grants) with a categorical bar on funds for entities tied to an injection center?
Those unanswered operational issues will determine the bill's real‑world impact more than its short operative sentence.
The Five Things You Need to Know
The bill conditions all Federal funding on compliance with 21 U.S.C. 856 by stating: 'No Federal funds may be made available' to any entity operating or controlling an injection center in violation of that statute.
It applies to State, local, Tribal, and private entities equally — the prohibition is not limited to governments or nonprofits alone.
The bill does not define 'injection center,' creating legal ambiguity about what facilities or activities the funding ban reaches.
The bill does not identify which federal funds are covered, nor does it set a compliance mechanism (no waiver, certification, audit, or timeline is specified).
The bill does not amend or change 21 U.S.C. 856 itself; it uses a funding condition to enforce compliance with the existing 'Crack House Statute.'.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
This single paragraph gives the Act its name, "Defund Heroin Injection Centers Act of 2025." It has no substantive effect but signals the bill's focus and likely enforcement goal: to use spending restrictions to discourage supervised injection sites.
Ban on federal funds for entities operating injection centers in violation of 21 U.S.C. 856
Section 2 contains the operative rule: a categorical prohibition on making Federal funds available to any State, local, Tribal, or private entity that operates or controls an injection center in violation of 21 U.S.C. 856. Because the text is terse, the provision leaves open critical implementation questions: whether agencies should determine violations based on convictions, arrest, reasonable belief, or administrative findings; whether the prohibition triggers automatic withholding or requires agency action; and whether affected entities lose all federal funding or only funds tied to particular programs. Agencies and courts would have to resolve those questions in practice.
Notable absences: definitions, scope, and enforcement mechanics
The bill does not define key terms such as "injection center," "operates or controls," or "Federal funds." It also does not prescribe an enforcement mechanism (for example, a state certification requirement, reporting obligations, or a civil penalty), nor does it provide exceptions or a waiver process. Those omissions create immediate compliance uncertainty: federal agencies that award grants would need to interpret the provision when setting award terms and may face litigation over any broad or retrospective application.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Local officials and community groups opposing supervised injection sites — The funding prohibition gives opponents a federal lever to block or raise the political and financial cost of opening such sites in their jurisdictions.
- Federal grantmakers and oversight agencies — Agencies can point to a clear congressional directive to deny or condition awards where they determine a violation exists, simplifying some funding decisions.
- Traditional treatment providers and abstinence‑based programs — If federal dollars shift away from entities operating supervised consumption facilities, competing treatment providers may see less competition for public funds and potential increases in referrals and funding.
Who Bears the Cost
- State and local public‑health departments planning or operating supervised consumption sites — They risk losing federal grants (public health, housing, EMS, or criminal justice funding) or facing increased compliance costs and legal exposure.
- Nonprofit harm‑reduction organizations and health systems — Private providers that operate safe consumption services could lose federal contract revenue, grants, or eligibility for other programs, impairing service delivery.
- Tribal governments — The text includes Tribal entities but provides no special accommodation for Tribal sovereignty or Indian Health Service funding, exposing Tribes to the same funding risk without tailored implementation guidance.
- Federal agencies and grant administrators — Agencies will face administrative burdens interpreting the statute, drafting new award conditions, and defending decisions in litigation; they may also need to develop monitoring and enforcement procedures with no guidance from the bill.
Key Issues
The Core Tension
The core tension is between using federal spending power to prevent facilities the federal government views as facilitating illegal drug use and preserving state, local, Tribal, and public‑health discretion to pursue harm‑reduction strategies; the bill solves one side of that tension (deterring injection centers) by adopting a blunt funding bar that creates legal ambiguity and practical collateral damage for public‑health programs and service providers.
The bill is legally blunt but operationally thin. It attempts to effect policy change by conditioning federal dollars on compliance with a criminal statute, rather than by modifying criminal law or specifying grant program rules.
That approach transfers a large interpretive burden to executive agencies and the courts: agencies must decide whether the ban applies only after a criminal conviction, upon reasonable belief of unlawful operation, or whenever an entity operates a facility that arguably facilitates drug use. Each standard has different legal risks and administrative costs.
The lack of definitions for key terms ("injection center," "operates or controls," and the scope of "Federal funds") creates room for wide divergence in implementation across agencies and likely litigation. The provision could be read narrowly (only applying post‑conviction to a specific facility) or broadly (exposing any entity linked to harm‑reduction activity to the loss of otherwise unrelated federal grants).
The uncertainty may chill lawful activities adjacent to supervised consumption, such as syringe exchange or medically supervised withdrawal services, and could complicate federally funded public‑health strategies that aim to reduce overdose deaths. The interaction with Tribal sovereignty and statutory programs that mandate certain services or funding uses adds another layer of legal complexity that the bill does not address.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.